Global Cell Lysis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
- SKU ID : GIR-GIR1807160130 12964724
- |
- Publishing Date: 15-Oct-2018
- |
- Region: Global
- |
- No. of pages: 112
Cell lysis is vital step for study or research in proteomics, as protein can only be extracted if the cell lysis process is conducted. Furthermore, cell lysis is crucial step required to perform for nuclear extraction, after which the DNA is modified using the recombinant DNA technology.
Scope of the Report:
This report studies the Cell Lysis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cell Lysis market by product type and applications/end industries.
The growing popularity of personalized medicines is one of the key factors driving the growth of this market in the next few years. The development of personalized medicine contributes to the exploration of new therapies for genetic anomalies. Genome mapping studies and the application of whole genome technology is extensively necessary to develop personalized medicines. The process of cell lysis is equally necessary to develop personalized medicine. Cell disruption is carried out to understand the interaction of cells. This helps researchers to develop or alter the structure of drugs to treat diseases. Additionally, the focus of the researchers to come up with new techniques such as reverse phase protein array (RPPA) technology for protein extraction to develop personalized medicine will also drive market growth since this technique involves homogenized cell lysis, which is performed using various methods.
Increasing cell-based research in North America due high demand for precision medicine is a major factor driving growth of the cell lysis market in this region. In 2015, the Precision Medicine Initiative was launched in the U.S. to revolutionize the treatment of diseases, which include cancer and other chronic diseases, as precision medicine offers tailored treatment for an individual according to genetic makeup of the person. The Asia Pacific region is also estimated to witness significant growth in cell lysis market, owing to increasing number of research laboratories and pharmaceutical companies with increased expenditure on research and development.
The global Cell Lysis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cell Lysis.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bio-Rad Laboratories
Beckman Coulter
Merck Millipore
Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Consumables
Instruments
Market Segment by Applications, can be divided into
Research Laboratories
Biopharmaceutical & Biotechnology Companies
Scope of the Report:
This report studies the Cell Lysis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cell Lysis market by product type and applications/end industries.
The growing popularity of personalized medicines is one of the key factors driving the growth of this market in the next few years. The development of personalized medicine contributes to the exploration of new therapies for genetic anomalies. Genome mapping studies and the application of whole genome technology is extensively necessary to develop personalized medicines. The process of cell lysis is equally necessary to develop personalized medicine. Cell disruption is carried out to understand the interaction of cells. This helps researchers to develop or alter the structure of drugs to treat diseases. Additionally, the focus of the researchers to come up with new techniques such as reverse phase protein array (RPPA) technology for protein extraction to develop personalized medicine will also drive market growth since this technique involves homogenized cell lysis, which is performed using various methods.
Increasing cell-based research in North America due high demand for precision medicine is a major factor driving growth of the cell lysis market in this region. In 2015, the Precision Medicine Initiative was launched in the U.S. to revolutionize the treatment of diseases, which include cancer and other chronic diseases, as precision medicine offers tailored treatment for an individual according to genetic makeup of the person. The Asia Pacific region is also estimated to witness significant growth in cell lysis market, owing to increasing number of research laboratories and pharmaceutical companies with increased expenditure on research and development.
The global Cell Lysis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cell Lysis.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bio-Rad Laboratories
Beckman Coulter
Merck Millipore
Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Consumables
Instruments
Market Segment by Applications, can be divided into
Research Laboratories
Biopharmaceutical & Biotechnology Companies
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
